Repository navigation
Issues
Issues
- SetaraBio/bio-news-agent#457 · opened
on Nov 12, 2026 - SetaraBio/bio-news-agent#456 · opened
on Nov 11, 2026 - SetaraBio/bio-news-agent#455 · opened
on Nov 10, 2026 - SetaraBio/bio-news-agent#453 · opened
on Nov 9, 2026 - SetaraBio/bio-news-agent#452 · opened
on Nov 8, 2026 - SetaraBio/bio-news-agent#451 · opened
on Nov 7, 2026 - SetaraBio/bio-news-agent#450 · opened
on Nov 6, 2026 - SetaraBio/bio-news-agent#449 · opened
on Nov 5, 2026 - SetaraBio/bio-news-agent#448 · opened
on Nov 4, 2026 - SetaraBio/bio-news-agent#445 · opened
on Nov 3, 2026 - SetaraBio/bio-news-agent#444 · opened
on Nov 3, 2026 - SetaraBio/bio-news-agent#443 · opened
on Oct 30, 2026 Biotech / Pharma Headlines - Oct 29: FDA outlines approval framework for personalized gene therapies
SetaraBio/bio-news-agent#442 · openedon Oct 29, 2026 - SetaraBio/bio-news-agent#441 · opened
on Oct 28, 2026 - SetaraBio/bio-news-agent#440 · opened
on Oct 27, 2026 - SetaraBio/bio-news-agent#439 · opened
on Oct 26, 2026 - SetaraBio/bio-news-agent#437 · opened
on Oct 25, 2026 - SetaraBio/bio-news-agent#436 · opened
on Oct 24, 2026 - SetaraBio/bio-news-agent#435 · opened
on Oct 23, 2026 - SetaraBio/bio-news-agent#434 · opened
on Oct 22, 2026 - SetaraBio/bio-news-agent#433 · opened
on Oct 21, 2026 - SetaraBio/bio-news-agent#432 · opened
on Oct 20, 2026 - SetaraBio/bio-news-agent#430 · opened
on Oct 19, 2026 - SetaraBio/bio-news-agent#429 · opened
on Oct 17, 2026 - SetaraBio/bio-news-agent#428 · opened
on Oct 16, 2026